Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Change in Receivables: 2009-2024

Historic Change in Receivables for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Dec 2024 value amounting to $22.0 million.

  • Avadel Pharmaceuticals' Change in Receivables fell 293.37% to -$5.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$8.7 million, marking a year-over-year decrease of 1982.58%. This contributed to the annual value of $22.0 million for FY2024, which is 81.72% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Change in Receivables of $22.0 million as of FY2024, which was up 81.72% from $12.1 million recorded in FY2023.
  • In the past 5 years, Avadel Pharmaceuticals' Change in Receivables ranged from a high of $22.0 million in FY2024 and a low of -$8.3 million during FY2020.
  • For the 2-year period, Avadel Pharmaceuticals' Change in Receivables averaged around $17.0 million, with its median value being $17.0 million (2023).
  • Per our database at Business Quant, Avadel Pharmaceuticals' Change in Receivables tumbled by 235.13% in 2020 and then surged by 81.72% in 2024.
  • Avadel Pharmaceuticals' Change in Receivables (Yearly) stood at -$8.3 million in 2020, then reached $12.1 million in 2023, then skyrocketed by 81.72% to $22.0 million in 2024.